PTHS – pelthos therapeutics inc. (US:NASDAQ)

News

Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice [Yahoo! Finance]
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
Ligand Pharmaceuticals Incorporated (LGND) Analyst/Investor Day Transcript [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com